About BITS Pilani
BITS Pilani is a Deemed-to-be University, offering on-campus programs to more than 18,500 students across its campuses in Pilani, Goa, Hyderabad, Mumbai, and Dubai. It has been recognized as an Institute of Eminence by the Ministry of Education, Government of India, in 2020. In QS Asia University Rankings 2023, BITS has been ranked 188th, the only private institute from India in Asia Top 200, and at 18 in India. Further, BITS Pilani has been ranked among the top 300 in QS World University Graduate Employability Rankings 2022 and within the top 8 in India. Having pioneered several curricular and pedagogic attributes, BITS Pilani has a vision to be amongst the top research-led Institutes in the country. The qualities of innovation, enterprise, commitment to excellence, adherence to merit, and transparency have characterized the Institute during its inexorable march to eminence. The Institute has secured over ₹398 crores as external research funding in the last fi ve years. State-of-the-art facilities have been developed to support cutting-edge research led by students and about 930 faculty members. This led to a Scopus h-index 156, with 221 patents filed and 41 patents granted. Currently, there are 14 BITSian Unicorns and 1 Decacorn. There are over 7500 BITSian founders and co-founders of enterprises.
The Department of Pharmacy at BITS Pilani, Pilani Campus, is one of the nation’s oldest pharmacy schools; the Department of Pharmacy at BITS Pilani was founded in 1950. We achieved the 3rd rank in 2023 and have constantly ranked in the top 5 by the NIRF (National Institutional Ranking Framework) in the Pharmacy category. In addition, over the previous two years, the QS world ranking for pharmacy and pharmacology has placed our department in the remarkable 100-150 range. We are actively involved in various research fi elds within the department, with a committed team of 15 faculty members and more than 63 research scholars. Numerous patents, faculty-led startups, research projects, and publications in prestigious journals with high-impact factors demonstrate our faculty member’s dedication to producing high-caliber research. The department has also given the technologies to the industry, and some of these products are
already on the market. Additionally, we have a cutting-edge infrastructure for drug discovery and product development. Our department is motivated by a compelling aim to establish itself as a premier global pharmaceutical research and teaching center.
The field of neurological disorders encompasses a diverse range of conditions that affect millions of people worldwide, presenting significant challenges to both patients and healthcare providers. This conference aims to address these challenges by bringing together experts from various disciplines to discuss recent advancements in understanding, diagnosing, and treating neurological disorders.
Key topics of discussion will include the latest research on the pathophysiology of neurological diseases such as Alzheimer’s, Parkinson’s, multiple sclerosis, and amyotrophic lateral sclerosis (ALS). We will explore innovative diagnostic techniques, including biomarkers and imaging technologies, which hold promise for earlier and more accurate detection of these conditions. Additionally, the conference will highlight cutting edge therapeutic approaches, from novel drug development to advanced neurostimulation techniques.
Despite these advancements, numerous obstacles remain, such as the complexity of disease mechanisms, the need for personalized treatment strategies, and the ethical considerations surrounding emerging therapies. Through collaborative efforts and interdisciplinary dialogue, this conference seeks to pave the way for future breakthroughs that will ultimately improve the quality of life for individuals affected by neurological disorders.
Themes
Role of Genetics and Epigenetics in Neurological Disorders
Cellular and Molecular Pathways in Neurological Disorders
Innovations in Neuroimaging Techniques and Developing Biomarkers for Early Detection
Novel Drug Development and Delivery Systems
Neurostimulation Techniques and Device-Based Therapies
Designing and Implementing Clinical Trials for Neurological Disorders
Addressing Mental Health and Cognitive Impairment in Neurological Disorders
Role of Artificial Intelligence and Machine Learning in Neurology
Roadmap for the Next Decade in Neurological Disorder Management
Challenges in Translating Research from Bench to Bedside
